{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17292492",
  "DateCompleted": {
    "Year": "2007",
    "Month": "07",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2007",
        "Month": "01",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0167-0115",
      "JournalIssue": {
        "Volume": "141",
        "Issue": "1-3",
        "PubDate": {
          "Year": "2007",
          "Month": "Jun",
          "Day": "07"
        }
      },
      "Title": "Regulatory peptides",
      "ISOAbbreviation": "Regul Pept"
    },
    "ArticleTitle": "N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.",
    "Pagination": {
      "StartPage": "154",
      "EndPage": "158",
      "MedlinePgn": "154-8"
    },
    "Abstract": {
      "AbstractText": [
        "Left ventricular end-diastolic pressure (LVEDP) during exercise workload is an important parameter to guide an exercise prescription for patients with cardiovascular disease. Plasma levels of neuro-hormonal factors can be used as a reflection of real-time LVEDP, but its utility is limited by its short half-life. By contrast, the N-terminal fragment of pro-ANP (NT-ANP) has a longer half-life of 1 h.",
        "To determine whether plasma NT-ANP levels at 30 min after exercise can be used as a marker of LVEDP during peak exercise workload in patients with previous myocardial infarction.",
        "Twenty patients with a previous history of myocardial infarction.",
        "Cardiopulmonary exercise test was performed to determine peak VO(2) and anaerobic threshold. Plasma levels of ANP, BNP, NT-ANP, vasopressin and plasma catecholamine were measured at rest, maximum exercise, and 30 min after exercise (recovery).",
        "With the exception of NT-ANP, the levels of each of neuro-hormonal factors peaked at maximum exercise and returned to baseline at recovery. By contrast, NT-ANP levels also increased at peak exercise but remained elevated at 30 min after exercise. Furthermore, NT-ANP levels at recovery correlated with ANP levels at maximum exercise (p<0.01, R=0.75), left ventricular ejection fraction (p<0.02, R=-0.54) and left ventricular systolic dimension (p<0.015, R=0.50).",
        "Plasma NT-ANP levels at 30 min after exercise reflect ANP levels at maximum exercise and left ventricular overload during exercise. These data indicate that plasma NT-ANP after exercise may be a useful parameter to guide prescription of cardiac rehabilitation."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Cardiovascular Division, Department of Integrated Medicine I, Omiya Medical Center, Jichi Medical School, 1-847 Amanuma, Saitama, Saitama 330-8503, Japan."
          }
        ],
        "LastName": "Ikeda",
        "ForeName": "Nahoko",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yasu",
        "ForeName": "Takanori",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nishikimi",
        "ForeName": "Toshio",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nakamura",
        "ForeName": "Tomohiro",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kubo",
        "ForeName": "Norifumi",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kawakami",
        "ForeName": "Masanobu",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Momomura",
        "ForeName": "Shin-ichi",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Saito",
        "ForeName": "Muneyasu",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Regul Pept",
    "NlmUniqueID": "8100479",
    "ISSNLinking": "0167-0115"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Catecholamines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Peptide Fragments"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Protein Precursors"
    },
    {
      "RegistryNumber": "11000-17-2",
      "NameOfSubstance": "Vasopressins"
    },
    {
      "RegistryNumber": "114471-18-0",
      "NameOfSubstance": "Natriuretic Peptide, Brain"
    },
    {
      "RegistryNumber": "85637-73-6",
      "NameOfSubstance": "Atrial Natriuretic Factor"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Atrial Natriuretic Factor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Blood Pressure"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Catecholamines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Half-Life"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Myocardial Infarction"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Natriuretic Peptide, Brain"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Oxygen Consumption"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Peptide Fragments"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Protein Precursors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Vasopressins"
    },
    {
      "QualifierName": [
        "rehabilitation"
      ],
      "DescriptorName": "Ventricular Dysfunction, Left"
    }
  ]
}